27738051|t|Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection
27738051|a|Natural infection induces partial immunity to Chlamydia trachomatis Identification of chlamydial antigens that induce interferon γ (IFN-) secretion by T cells from immune women could advance vaccine development. IFN-γ production by CD4(+) and CD8(+) peripheral blood T cells from 58 high-risk women was measured after coculture with antigen-presenting cells preincubated with recombinant Escherichia coli expressing a panel of 275 chlamydial antigens. Quantile median regression analysis was used to compare frequencies of IFN-γ responses in women with only cervical infection to those in women with endometrial infection and frequencies in women who remained uninfected for over 1 year to those in women who developed incident infection. Statistical methods were then used to identify proteins associated with protection. A higher median frequency of CD8(+) T-cell responses was detected in women with lower genital tract chlamydial infection, compared with those with upper genital tract chlamydial infection (13.8% vs 9.5%; P =04), but the CD4(+) T-cell response frequencies were not different. Women who remained uninfected displayed a greater frequency of positive CD4(+) T-cell responses (29% vs 18%; P < .0001), compared with women who had incident infection, while the frequencies of CD8(+) T-cell responses did not differ. A subset of proteins involved in central metabolism, type III secretion, and protein synthesis were associated with protection. Investigations in naturally exposed women reveal protective responses and identify chlamydial vaccine candidate antigens.
27738051	18	48	Chlamydia trachomatis Antigens	T103	UMLS:C0368903
27738051	63	70	T Cells	T017	UMLS:C0039194
27738051	91	96	Women	T098	UMLS:C0043210
27738051	117	140	Genital Tract Infection	T038	UMLS:C1263758
27738051	149	158	infection	T038	UMLS:C3714514
27738051	175	183	immunity	T038	UMLS:C0020964
27738051	187	208	Chlamydia trachomatis	T007	UMLS:C0008151
27738051	227	246	chlamydial antigens	T103	UMLS:C0368903
27738051	259	271	interferon γ	T103	UMLS:C3539881
27738051	273	277	IFN-	T103	UMLS:C3539881
27738051	279	288	secretion	T038	UMLS:C1327616
27738051	292	299	T cells	T017	UMLS:C0039194
27738051	312	317	women	T098	UMLS:C0043210
27738051	332	351	vaccine development	T062	UMLS:C0597634
27738051	353	358	IFN-γ	T103	UMLS:C3539881
27738051	373	379	CD4(+)	T017	UMLS:C0039215
27738051	384	390	CD8(+)	T017	UMLS:C0242629
27738051	391	407	peripheral blood	T031	UMLS:C0229664
27738051	408	415	T cells	T017	UMLS:C0039194
27738051	434	439	women	T098	UMLS:C0043210
27738051	459	468	coculture	T058	UMLS:C0282547
27738051	474	498	antigen-presenting cells	T017	UMLS:C0003315
27738051	529	545	Escherichia coli	T007	UMLS:C0014834
27738051	572	591	chlamydial antigens	T103	UMLS:C0368903
27738051	593	628	Quantile median regression analysis	T170	UMLS:C0034980
27738051	664	669	IFN-γ	T103	UMLS:C3539881
27738051	670	679	responses	T038	UMLS:C0301872
27738051	683	688	women	T098	UMLS:C0043210
27738051	730	735	women	T098	UMLS:C0043210
27738051	741	752	endometrial	T017	UMLS:C0014180
27738051	753	762	infection	T038	UMLS:C3714514
27738051	782	787	women	T098	UMLS:C0043210
27738051	840	845	women	T098	UMLS:C0043210
27738051	869	878	infection	T038	UMLS:C3714514
27738051	880	899	Statistical methods	T062	UMLS:C1710191
27738051	927	935	proteins	T103	UMLS:C0033684
27738051	952	962	protection	T038	UMLS:C0020964
27738051	993	1006	CD8(+) T-cell	T017	UMLS:C0242629
27738051	1007	1016	responses	T038	UMLS:C1318468
27738051	1033	1038	women	T098	UMLS:C0043210
27738051	1044	1049	lower	T082	UMLS:C0441994
27738051	1050	1063	genital tract	T022	UMLS:C0700038
27738051	1064	1084	chlamydial infection	T038	UMLS:C0008149
27738051	1111	1116	upper	T082	UMLS:C1282910
27738051	1117	1130	genital tract	T022	UMLS:C0700038
27738051	1131	1151	chlamydial infection	T038	UMLS:C0008149
27738051	1184	1197	CD4(+) T-cell	T017	UMLS:C0039215
27738051	1239	1244	Women	T098	UMLS:C0043210
27738051	1311	1324	CD4(+) T-cell	T017	UMLS:C0039215
27738051	1325	1334	responses	T038	UMLS:C1318468
27738051	1374	1379	women	T098	UMLS:C0043210
27738051	1397	1406	infection	T038	UMLS:C3714514
27738051	1433	1446	CD8(+) T-cell	T017	UMLS:C0242629
27738051	1447	1456	responses	T038	UMLS:C1318468
27738051	1475	1481	subset	T170	UMLS:C1515021
27738051	1485	1493	proteins	T103	UMLS:C0033684
27738051	1506	1524	central metabolism	T038	UMLS:C0025519
27738051	1526	1544	type III secretion	T038	UMLS:C3156721
27738051	1550	1567	protein synthesis	T038	UMLS:C0597295
27738051	1589	1599	protection	T038	UMLS:C0020964
27738051	1637	1642	women	T098	UMLS:C0043210
27738051	1661	1670	responses	T038	UMLS:C1318468
27738051	1684	1721	chlamydial vaccine candidate antigens	T103	UMLS:C1519887